» Articles » PMID: 22078875

Autophagy: Renovation of Cells and Tissues

Overview
Journal Cell
Publisher Cell Press
Specialty Cell Biology
Date 2011 Nov 15
PMID 22078875
Citations 2952
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is the major intracellular degradation system by which cytoplasmic materials are delivered to and degraded in the lysosome. However, the purpose of autophagy is not the simple elimination of materials, but instead, autophagy serves as a dynamic recycling system that produces new building blocks and energy for cellular renovation and homeostasis. Here we provide a multidisciplinary review of our current understanding of autophagy's role in metabolic adaptation, intracellular quality control, and renovation during development and differentiation. We also explore how recent mouse models in combination with advances in human genetics are providing key insights into how the impairment or activation of autophagy contributes to pathogenesis of diverse diseases, from neurodegenerative diseases such as Parkinson disease to inflammatory disorders such as Crohn disease.

Citing Articles

Unleashing the power of peptides in prostate cancer immunotherapy: mechanism, facts and perspectives.

Li X, Yang F, Wang M, Huang X, Zeng X, Zhou L Front Pharmacol. 2025; 16:1478331.

PMID: 40078274 PMC: 11897510. DOI: 10.3389/fphar.2025.1478331.


Linoleic acid inhibits lipopolysaccharide-induced inflammation by promoting TLR4 regulated autophagy in murine RAW264.7 macrophages.

Qin Y, Li K, Zhang Q, Liu J, Xie Y, Zhang T J Appl Biomed. 2025; 22(4):185-196.

PMID: 40033806 DOI: 10.32725/jab.2024.023.


A narrative review of autophagy in migraine.

Huang Y, Li H, Yu Q, Pan Y Front Neurosci. 2025; 19:1500189.

PMID: 40027467 PMC: 11868061. DOI: 10.3389/fnins.2025.1500189.


Loss of TC-PTP in keratinocytes leads to increased UVB-induced autophagy.

Asare O, Shim L, Lee C, Delgado J, Quailes N, Zavala K Cell Death Discov. 2025; 11(1):80.

PMID: 40021617 PMC: 11871011. DOI: 10.1038/s41420-025-02353-8.


Caveolin-3: therapeutic target for diabetic myocardial ischemia/reperfusion injury.

Wen X, Ji Y, Tang H, Jin Z, Su W, Zhou L Mol Med. 2025; 31(1):80.

PMID: 40012041 PMC: 11866611. DOI: 10.1186/s10020-025-01117-5.